GlaxoSmithKline (GSK)

Add a New Bears Reason Company: GlaxoSmithKline (GSK) Current price: Headline: (100 character max) Analysis: Cancel 30% agree 10 votes   Cevarix might lose to Merck's first-mover advantage Top Contributor: Shai Bronshtein | Created when NYSE:GSK was $53.07 | Edit | History Although Cervarix looks to be a hit, Merck’s Gardasil launched in 2006 will have had almost a year and a half to gain market share before the new competitor arises. At that point, Gardasil will have been a “tried and true” product, making entry more difficult for Cevarix. (100 character max) Cancel 0% agree 5 votes   More Avandia Payouts for GSK Created when NYSE:GSK was $33.46 | Edit | History GSK settles more lawsuits but will face a courtdate in Oct. that could be cost the greedy British drugmaker millions of dollars. GSK has recently been cited for treating its sales force like a mafia kingpin hiring former FBI and New York City police detectives to investigate their own people to get them fired for charges that the company itself ordered their rep's to do. These ruthless tactics will eventually cost the them huge sales as they lose credability with Doctors. (100 character max) Cancel 11% agree 9 votes   Losing patents Top Contributor: Shai Bronshtein | Created when NYSE:GSK was $53.07 | Edit | History GlaxoSmithKline will lose several patents in the next three years, including antidepressants Wellbutrin and Paxil as well as epilepsy and bipolar drug Lamictal (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.